CS logo
small CS logo
National Hospital Organization Kobe Medical Center

Kobe, Hyogo, Japan
Medical center in Kobe
〒654-0155 Hyogo, Kobe, Suma Ward, Nishiochiai, 3 Chome−1−1 神戸医療センタ 1F

About National Hospital Organization Kobe Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Bayer
4
Boehringer Ingelheim
2
Ferring Pharmaceuticals
1
GOG Foundation
1
Gynecologic Oncology Group
1
National Cancer Institute (NCI)
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Total Rows: 7

Clinical Trials at National Hospital Organization Kobe Medical Center


During the past decade, National Hospital Organization Kobe Medical Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years4411001100110022Started TrialsCompleted Trails20172018201920200246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
2000-11-20
2016-07-16
Completed
31
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2005-09-01
2015-04-01
Completed
1,873
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia
2007-01-12
2008-08-19
Completed
126
Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo
2010-07-01
2011-04-01
Completed
116
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects
2017-12-12
2019-10-11
Completed
162

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "National Hospital Organization Kobe Medical Center" #1 sponsor was "Bayer" with 4 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored, "GOG Foundation" with 1 trials sponsored and "Gynecologic Oncology Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kobe Medical Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBayer: 4Bayer: 4Boehringer Ingelheim: 2Boehringer Ingelheim: 2Ferring Pharmaceuticals: 1Ferring Pharmaceuticals: 1GOG Foundation: 1GOG Foundation: 1Gynecologic Oncology Group: 1Gynecologic Oncology Group: 1National Cancer Institute (NCI): 1National Cancer Institute (NCI): 1Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 1Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2National Cancer Institute (NCI): 2National Cancer Institute (NCI): 2Canadian VIGOUR Centre: 1Canadian VIGOUR Centre: 1Duke Clinical ResearchInstitute: 1Duke Clinical ResearchInstitute: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1NRG Oncology: 1NRG Oncology: 1

Clinical Trials Conditions at National Hospital Organization Kobe Medical Center


According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kobe Medical Center" are "Heart Failure" (3 trials), "Anemia" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Adult Type Ovarian Granulosa Cell Tumor" (1 trials) and "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "National Hospital Organization Kobe Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at National Hospital Organization Kobe Medical Center


Most popular intervention types in "National Hospital Organization Kobe Medical Center" are "Drug" (11 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Paclitaxel" (3 trials), "Carboplatin" (2 trials), "Darbepoetin alfa" (2 trials) and "Empagliflozin" (2 trials). Other intervention names were less common.

Clinical Trials Genders at National Hospital Organization Kobe Medical Center


The vast majority of trials in "National Hospital Organization Kobe Medical Center" are 8 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at National Hospital Organization Kobe Medical Center


Currently, there are NaN active trials in "National Hospital Organization Kobe Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in National Hospital Organization Kobe Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Hospital Organization Kobe Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 10Completed: 10Active, not recruiting: 1Active, not recruiting: 1